TD Cowen cuts STMicroelectronics to Hold
TD Cowen analyst Daniel Brennan maintained a Hold rating on 10x Genomics (TXG – Research Report) today and set a price target of $18.00. The ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.39% of ...
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.
El Lilly’s blockbuster weight-loss drug Zepbound is now eligible for coverage under Medicare prescription drug plans, when ...
Shares of American Airlines surged Monday after brokerages Jefferies and TD Cowen upgraded and raised their price targets on ...
Lisa Thomas, Managing Director and Deputy Head of Global Research at TD Cowen, discusses some of the key findings of a new TD Cowen report on the big investment themes of 2025, including shifting ...
On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...
TD Cowen raised the firm’s price target on Delta Air Lines (DAL) to $90 from $78 and keeps a Buy rating on the shares. The firm updated its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback